More about
Therapy-Related Cardiac Dysfunction
News
September 23, 2024
3 min read
Save
SGLT2s could prevent cardiotoxic effects of cancer therapies in patients with diabetes
SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy, researchers reported.